P2.14-09 Concurrent TP53 Mutation Adversely Impact the Efficacy of Crizotinib in ROS1-Rearranged Lung Cancer PatientsG. Lin,H. Xu,J. Zhao,J. Kong,X. Ai,F. Yu,K. Du,L. Zhu,L. Li,H. Ma,Q. Wang,H. Xiong,R. Chen,X. XiaJournal of Thoracic Oncology(2019)引用 4|浏览2暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要